Lifeboat Foundation

Quarantine amid coronavirus could boost the nascent practice of seeking romance and friendship from artificial intelligence.

An early analysis of remdesivir, a drug developed by pharmaceutical firm Gilead, has shown that it may have improved severe symptoms of COVID-19 in 68% of patients after 18 days.

For the Gilead-funded study, doctors recruited 61 patients hospitalized with COVID-19 with oxygen saturation of 94% or less while breathing ambient air or receiving oxygen support. To receve remdesivir on a compassionate use basis (a program allowing the use of unapproved medicines when no other treatment options are available), on the first day of treatment, patients were administered 200mg of remesdevir, and then 100 mg daily on the remaining 9 days of treatment.

Continue reading “Remdesivir Improves COVID-19 Symptoms in 68% of Patients in Early Study” »

The FDA issued the emergency authorization to use blood purification devices to treat coronavirus patients on Friday.

Forced to stay at home amid the coronavirus pandemic, more residents of Christianburg, Virginia, are ordering from a pilot drone residential delivery service run by Google parent Alphabet. The most popular items: Coffee, toilet paper and cookies.

Around a year ago…

Pretty cool.

Continue reading “Remote surgery using robots advances with 5G tests in China” »

Within a week, many world leaders went from downplaying the seriousness of coronavirus to declaring a state of emergency. Even the most efficacious of nations seem to be simultaneously confused and exasperated, with delayed responses revealing incompetence and inefficiency the world over.

So this begs the question: why is it so difficult for us to comprehend the scale of what an unmitigated global pandemic could do? The answer likely relates to how we process abstract concepts like exponential growth. Part of the reason we’ve struggled so much applying basic math to our practical environment is because humans think linearly. But like much of technology, biological systems such as viruses can grow exponentially.

As we scramble to contain and fight the pandemic, we’ve turned to technology as our saving grace. In doing so, we’ve effectively hit a “fast-forward” button on many tech trends that were already in place. From remote work and virtual events to virus-monitoring big data, technologies that were perhaps only familiar to a fringe tech community are now entering center stage—and as tends to be the case with wartime responses, these changes are likely here to stay.

Findings In a case series of 214 patients with coronavirus disease 2019, neurologic symptoms were seen in 36.4% of patients and were more common in patients with severe infection (45.5%) according to their respiratory status, which included acute cerebrovascular events, impaired consciousness, and muscle injury.

Published Online: April 10, 2020. doi: 10.1001/jamaneurol.2020.1127

Author Contributions: Dr B. Hu had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Mao, Jin, M. Wang, Y. Hu, Chen, He, and Chang contributed equally and share first authorship.

Continue reading “Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China” »

The precious metal has been torn between its potential as a haven investment and a mad scramble to sell the tangible asset in a bid for cash to cover losses in the stock market.

“The Covid-19 outbreak has had a major impact on the gold market, bringing massive price swings as investors react to new developments related to the pandemic,” says Steven Dunn, head of exchange-traded funds at Aberdeen Standard Investments.

“Because of Covid-19, refiners were knocked offline…and the ability to move gold became a challenge as normal means of transport became almost impossible,” he says.

Pangolins, not snakes, may be the missing link for transmission of the new coronavirus from bats to humans.

Since its initial outbreak at Huanan Seafood Wholesale Market in Wuhan, China, in late 2019, COVID-19 has since infected more than a million people across the globe. To understand and control the transmission of COVID-19, scientists are racing to study the coronavirus causing the disease: SARS-CoV-2, previously named 2019-nCoV.

SARS-CoV-2 is zoonotic, which means that the virus originated in animals and jumped to humans. A critical challenge is to determine which animal transmitted the virus to humans.